A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to demonstrate the higher efficacy of small particles
Foster® 100/6 (two puffs b.i.d.) versus large particles Symbicort® 200/6 (two inhalations
b.i.d.), in terms of residual volume reduction over a 12-week treatment period in Chronic
Obstructive Pulmonary Disease (COPD) patients.
Phase:
Phase 3
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Treatments:
Beclomethasone Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate